Strategic partnerships Aptar Digital Health has a track record of forming strategic partnerships with biopharma and healthcare innovators (Biogen, AstraZeneca, Enable Injections, OURA) to develop digital health solutions and integrated delivery systems, indicating strong potential for co-development and licensing opportunities.

Healthcare integration The company focuses on end-to-end digital health ecosystems including connected drug delivery, mobile and web apps, onboarding, training, and advanced data analytics, presenting opportunities to upsell platform integrations with EHRs, patient portals, and remote monitoring for pharmaceutical and device manufacturers.

Neurology and rare diseases Past and ongoing engagements with Biogen and QoL research collaborators highlight a specialization in neurological and rare disease patient journeys, suggesting sales potential with pharma and biotech firms pursuing digital triage, adherence, and patient support solutions.

Wearables and data Partnerships involving Oura Ring integration and AI-powered screening indicate a preference for wearable-enabled patient insights and analytics, offering upsell prospects for sensors, data pipelines, and AI-enabled patient risk stratification for manufacturers and payers.

Global health scale With a global leadership claim in dosing and protection technologies and a growing digital health portfolio, Aptar Digital Health presents a pathway for expansion through licensing, co-development, and capability expansions with large medical device and pharma players seeking scalable digital patient experiences.